Inhibition of mTORC2/RICTOR Impairs Melanoma Hepatic Metastasis

Schmidt, Katharina M. and Dietrich, Peter and Hackl, Christina and Guenzle, Jessica and Bronsert, Peter and Wagner, Christine and Fichtner-Feigl, Stefan and Schlitt, Hans J. and Geissler, Edward K. and Hellerbrand, Claus and Lang, Sven A. (2018) Inhibition of mTORC2/RICTOR Impairs Melanoma Hepatic Metastasis. NEOPLASIA, 20 (12). pp. 1198-1208. ISSN 1476-5586,

Full text not available from this repository. (Request a copy)

Abstract

Mammalian target of rapamycin complex 2 (mTORC2) with its pivotal component rapamycin-insensitive companion of mTOR (RICTOR) is the major regulator of AKT phosphorylation and is increasingly implicated in tumor growth and progression. In cutaneous melanoma, an extremely aggressive and highly metastatic disease, RICTOR overexpression is involved in tumor development and invasiveness. Therefore, we investigated the impact of RICTOR inhibition in melanoma cells in vitro and in vivo with special emphasis on hepatic metastasis. Moreover, our study focused on the interaction of tumor cells and hepatic stellate cells (HSC) which play a crucial role in the hepatic microenvironment. In silico analysis revealed increased RICTOR expression in melanoma cells and tissues and indicated higher expression in advanced melanoma stages and metastases. In vitro, transient RICTOR knock-down via siRNA caused a significant reduction of tumor cell motility. Using a syngeneic murine splenic injection model, a significant decrease in liver metastasis burden was detected in vivo. Moreover, stimulation of melanoma cells with conditioned medium (CM) from activated HSC or hepatocyte growth factor (HGF) led to a significant induction of AKT phosphorylation and tumor cell motility. Blocking of RICTOR expression in cancer cells diminished constitutive and HGF-induced AKT phosphorylation as well as cell motility. Interestingly, RICTOR blockade also led to an abrogation of CM-induced effects on AKT phosphorylation and motility in melanoma cells. In conclusion, these results provide first evidence for a critical role of mTORC2/RICTOR in melanoma liver metastasis via cancer cell/HSC interactions.

Item Type: Article
Uncontrolled Keywords: STELLATE CELLS; HEPATOCELLULAR-CARCINOMA; LIVER METASTASIS; CUTANEOUS MELANOMA; COLORECTAL-CANCER; IN-VITRO; EXPRESSION; PATHWAY; RICTOR; MTOR;
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Unfallchirurgie
Depositing User: Dr. Gernot Deinzer
Date Deposited: 07 Oct 2019 13:04
Last Modified: 07 Oct 2019 13:04
URI: https://pred.uni-regensburg.de/id/eprint/13466

Actions (login required)

View Item View Item